(EXO) Exor - Ratings and Ratios
Automobiles, Agricultural Equipment, Sports Cars, Commercial Vehicles, Media
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.68% |
| Yield on Cost 5y | 0.75% |
| Yield CAGR 5y | 4.55% |
| Payout Consistency | 100.0% |
| Payout Ratio | 0.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.8% |
| Value at Risk 5%th | 33.2% |
| Relative Tail Risk | -2.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.88 |
| Alpha | -24.17 |
| CAGR/Max DD | 0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.620 |
| Beta | 0.240 |
| Beta Downside | 0.319 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.47% |
| Mean DD | 9.26% |
| Median DD | 6.67% |
Description: EXO Exor December 17, 2025
Exor N.V. is a diversified holding company that controls leading brands across automotive, industrial, media, and sports sectors, including Ferrari, Stellantis, CNH Industrial, Iveco Group, Juventus FC, and GEDI. Through these subsidiaries it designs, manufactures and sells luxury sports cars, mass-market vehicles, agricultural and construction equipment, powertrain technologies, and a range of media and consumer-goods products.
In FY 2023 the group reported consolidated revenue of roughly €30.5 billion, with Ferrari contributing €5.6 billion and delivering a 12 % increase in net profit year-over-year. Stellantis, Exor’s largest automotive stake, saw EV sales rise about 30 % YoY, reflecting the broader industry shift toward electrification, while CNH Industrial’s order intake grew 7 % in Q3 2024, driven by stronger demand for precision farming equipment. Key macro drivers for Exor’s portfolio include tightening emissions regulations, supply-chain bottlenecks in semiconductors, and inflation-linked cost pressures that affect both consumer-vehicle pricing and industrial-equipment margins.
For a deeper quantitative breakdown, ValueRay’s platform offers granular, real-time metrics on Exor’s holdings.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (4.19b TTM) > 0 and > 6% of Revenue (6% = 2.68b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 5.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.67% (prev 36.97%; Δ -38.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 6.25b > Net Income 4.19b (YES >=105%, WARN >=100%) |
| Net Debt (1.97b) to EBITDA (6.43b) ratio: 0.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (201.5m) change vs 12m ago -10.50% (target <= -2.0% for YES) |
| Gross Margin 25.27% (prev 22.72%; Δ 2.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 66.39% (prev 44.15%; Δ 22.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 46.80 (EBITDA TTM 6.43b / Interest Expense TTM 113.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.17
| (A) -0.02 = (Total Current Assets 339.0m - Total Current Liabilities 1.09b) / Total Assets 40.00b |
| (B) -0.02 = Retained Earnings (Balance) -624.0m / Total Assets 40.00b |
| (C) 0.08 = EBIT TTM 5.29b / Avg Total Assets 67.39b |
| (D) -0.17 = Book Value of Equity -624.0m / Total Liabilities 3.64b |
| Total Rating: 0.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.21
| 1. Piotroski 9.0pt |
| 2. FCF Yield 13.18% |
| 3. FCF Margin 7.68% |
| 4. Debt/Equity 0.11 |
| 5. Debt/Ebitda 0.31 |
| 6. ROIC - WACC (= 3.61)% |
| 7. RoE 12.32% |
| 8. Rev. Trend 90.28% |
| 9. EPS Trend -18.74% |
What is the price of EXO shares?
Over the past week, the price has changed by +0.42%, over one month by -0.96%, over three months by -13.41% and over the past year by -19.20%.
Is EXO a buy, sell or hold?
What are the forecasts/targets for the EXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.7 | 62.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 65.6 | -9.3% |
EXO Fundamental Data Overview December 12, 2025
Market Cap EUR = 23.51b (23.51b EUR * 1.0 EUR.EUR)
P/S = 1.7692
P/B = 0.3991
Beta = 0.404
Revenue TTM = 44.74b EUR
EBIT TTM = 5.29b EUR
EBITDA TTM = 6.43b EUR
Long Term Debt = 3.04b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.05b EUR (from shortLongTermDebt, last fiscal year)
Debt = 4.09b EUR (Calculated: Short Term 1.05b + Long Term 3.04b)
Net Debt = 1.97b EUR (from netDebt column, last quarter)
Enterprise Value = 26.07b EUR (23.51b + Debt 4.09b - CCE 1.53b)
Interest Coverage Ratio = 46.80 (Ebit TTM 5.29b / Interest Expense TTM 113.0m)
FCF Yield = 13.18% (FCF TTM 3.44b / Enterprise Value 26.07b)
FCF Margin = 7.68% (FCF TTM 3.44b / Revenue TTM 44.74b)
Net Margin = 9.37% (Net Income TTM 4.19b / Revenue TTM 44.74b)
Gross Margin = 25.27% ((Revenue TTM 44.74b - Cost of Revenue TTM 33.43b) / Revenue TTM)
Gross Margin QoQ = 24.75% (prev 24.75%)
Tobins Q-Ratio = 0.65 (Enterprise Value 26.07b / Total Assets 40.00b)
Interest Expense / Debt = 2.76% (Interest Expense 113.0m / Debt 4.09b)
Taxrate = 12.89% (243.5m / 1.89b)
NOPAT = 4.61b (EBIT 5.29b * (1 - 12.89%))
Current Ratio = 0.31 (Total Current Assets 339.0m / Total Current Liabilities 1.09b)
Debt / Equity = 0.11 (Debt 4.09b / totalStockholderEquity, last quarter 36.35b)
Debt / EBITDA = 0.31 (Net Debt 1.97b / EBITDA 6.43b)
Debt / FCF = 0.57 (Net Debt 1.97b / FCF TTM 3.44b)
Total Stockholder Equity = 34.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.49% (Net Income 4.19b / Total Assets 40.00b)
RoE = 12.32% (Net Income TTM 4.19b / Total Stockholder Equity 34.04b)
RoCE = 14.26% (EBIT 5.29b / Capital Employed (Equity 34.04b + L.T.Debt 3.04b))
RoIC = 9.84% (NOPAT 4.61b / Invested Capital 46.80b)
WACC = 6.23% (E(23.51b)/V(27.60b) * Re(6.90%) + D(4.09b)/V(27.60b) * Rd(2.76%) * (1-Tc(0.13)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 3.71%
[DCF Debug] Terminal Value 72.13% ; FCFE base≈3.05b ; Y1≈2.16b ; Y5≈1.15b
Fair Price DCF = 109.5 (DCF Value 22.06b / Shares Outstanding 201.5m; 5y FCF grow -34.29% → 3.0% )
EPS Correlation: -18.74 | EPS CAGR: 477.7% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.28 | Revenue CAGR: 24.50% | SUE: 1.13 | # QB: 1
EPS next Year (2026-12-31): EPS=1.93 | Chg30d=-1.380 | Revisions Net=-1 | Growth EPS=+113.0% | Growth Revenue=+0.0%